| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PHAS | PhaseBio Pharmaceuticals Inc | Sharp John P | Chief Financial Officer | May 20, 2022 | Option Exercise | $0.68 | 6,026 | 4,106 | 65,767 | May 24, 2022, 05:12 PM | |
| PHAS | PhaseBio Pharmaceuticals Inc | Sharp John P | Chief Financial Officer | Nov 19, 2021 | Option Exercise | $2.01 | 2,017 | 4,054 | 59,741 | Nov 23, 2021, 06:53 PM | |
| PHAS | PhaseBio Pharmaceuticals Inc | Sharp John P | Chief Financial Officer | Nov 03, 2021 | Option Exercise | $1.68 | 7,500 | 12,600 | 57,724 | Nov 03, 2021, 07:30 PM | |
| PHAS | PhaseBio Pharmaceuticals Inc | Sharp John P | Chief Financial Officer | Aug 03, 2021 | Option Exercise | $1.68 | 7,500 | 12,600 | 50,224 | Sep 03, 2021, 04:41 PM | |
| PHAS | PhaseBio Pharmaceuticals Inc | Sharp John P | Chief Financial Officer | Aug 03, 2021 | Option Exercise | $1.68 | 7,500 | 12,600 | 50,224 | Aug 04, 2021, 06:58 PM | |
| PHAS | PhaseBio Pharmaceuticals Inc | Sharp John P | Chief Financial Officer | Nov 20, 2020 | Option Exercise | $3.00 | 1,305 | 3,915 | 41,305 | Nov 23, 2020, 06:43 PM | |
| PHAS | PhaseBio Pharmaceuticals Inc | Sharp John P | Chief Financial Officer | Aug 14, 2020 | Option Exercise | $1.69 | 5,000 | 8,450 | 40,000 | Aug 17, 2020, 08:15 PM | |
| PHAS | PhaseBio Pharmaceuticals Inc | Sharp John P | CFO and Secretary | Aug 21, 2019 | Option Exercise | $1.61 | 15,000 | 24,100 | 35,000 | Aug 22, 2019, 07:42 PM | |
| PHAS | PhaseBio Pharmaceuticals Inc | Sharp John P | CFO and Secretary | May 22, 2019 | Option Exercise | $1.69 | 15,000 | 25,350 | 20,000 | May 24, 2019, 02:22 PM | |
| PHAS | PhaseBio Pharmaceuticals Inc | Sharp John P | CFO and Secretary | Dec 07, 2018 | Buy | $3.84 | 5,000 | 19,200 | 5,000 | Dec 11, 2018, 04:16 PM | |
| LGND | LIGAND PHARMACEUTICALS INC | Sharp John P | VP Finance and CFO | Feb 12, 2014 | Sale | $46.16 | 173,906 | 8,026,958 | 34,333 | Feb 14, 2014, 08:18 PM | |
| LGND | LIGAND PHARMACEUTICALS INC | Sharp John P | VP Finance and CFO | Dec 12, 2013 | Sale | $31.70 | 1,400 | 44,380 | 18,367 | Dec 16, 2013, 05:09 PM | |
| LGND | LIGAND PHARMACEUTICALS INC | Sharp John P | VP Finance and CFO | Dec 06, 2013 | Sale | $56.08 | 6,000 | 336,480 | 17,667 | Dec 09, 2013, 06:53 PM | |
| LGND | LIGAND PHARMACEUTICALS INC | Sharp John P | VP Finance and CFO | Nov 18, 2013 | Option Exercise | $37.63 | 1,747 | 65,734 | 24,790 | Nov 20, 2013, 06:49 PM | |
| LGND | LIGAND PHARMACEUTICALS INC | Sharp John P | VP Finance and CFO | Aug 16, 2013 | Sale | $26.35 | 15,000 | 395,319 | 31,666 | Aug 20, 2013, 06:44 PM |
Menu